TY - JOUR PY - 2001 DA - 2001// TI - Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.19.2486 DO - 10.1001/jama.285.19.2486 ID - ref1 ER - TY - JOUR AU - Graham, I. AU - Atar, D. AU - Borch-Johnsen, K. AU - Boysen, G. AU - Burell, G. AU - Cifkova, R. AU - Dallongeville, J. AU - De Backer, G. AU - Ebrahim, S. AU - Gjelsvik, B. PY - 2007 DA - 2007// TI - European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) JO - Eur J Cardiovasc Prev Rehabil VL - 14 UR - https://doi.org/10.1097/01.hjr.0000277983.23934.c9 DO - 10.1097/01.hjr.0000277983.23934.c9 ID - Graham2007 ER - TY - JOUR AU - Ballantyne, C. M. AU - Bertolami, M. AU - Hernandez Garcia, H. R. AU - Nul, D. AU - Stein, E. A. AU - Theroux, P. AU - Weiss, R. AU - Cain, V. A. AU - Raichlen, J. S. PY - 2006 DA - 2006// TI - Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II JO - Am Heart J VL - 151 UR - https://doi.org/10.1016/j.ahj.2005.12.013 DO - 10.1016/j.ahj.2005.12.013 ID - Ballantyne2006 ER - TY - JOUR AU - Cheng, J. W. PY - 2004 DA - 2004// TI - Rosuvastatin in the management of hyperlipidemia JO - Clin Ther VL - 26 UR - https://doi.org/10.1016/j.clinthera.2004.09.005 DO - 10.1016/j.clinthera.2004.09.005 ID - Cheng2004 ER - TY - JOUR AU - Jones, P. H. AU - Davidson, M. H. AU - Stein, E. A. AU - Bays, H. E. AU - McKenney, J. M. AU - Miller, E. AU - Cain, V. A. AU - Blasetto, J. W. PY - 2003 DA - 2003// TI - Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) JO - Am J Cardiol VL - 92 UR - https://doi.org/10.1016/S0002-9149(03)00530-7 DO - 10.1016/S0002-9149(03)00530-7 ID - Jones2003 ER - TY - JOUR AU - Graham, I. AU - Atar, D. AU - Borch-Johnsen, K. AU - Boysen, G. AU - Burell, G. AU - Cifkova, R. AU - Dallongeville, J. AU - De Backer, G. AU - Ebrahim, S. AU - Gjelsvik, B. PY - 2007 DA - 2007// TI - European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) JO - Eur J Cardiovasc Prev Rehabil VL - 14 UR - https://doi.org/10.1097/01.hjr.0000277983.23934.c9 DO - 10.1097/01.hjr.0000277983.23934.c9 ID - Graham2007 ER - TY - JOUR AU - Kotseva, K. AU - Wood, D. AU - De Backer, G. AU - De Bacquer, D. AU - Pyorala, K. AU - Keil, U. PY - 2009 DA - 2009// TI - EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries JO - Eur J Cardiovasc Prev Rehabil VL - 16 UR - https://doi.org/10.1097/HJR.0b013e3283294b1d DO - 10.1097/HJR.0b013e3283294b1d ID - Kotseva2009 ER - TY - JOUR AU - Pearson, T. A. AU - Laurora, I. AU - Chu, H. AU - Kafonek, S. PY - 2000 DA - 2000// TI - The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals JO - Arch Intern Med VL - 160 UR - https://doi.org/10.1001/archinte.160.4.459 DO - 10.1001/archinte.160.4.459 ID - Pearson2000 ER - TY - JOUR AU - McCormack, T. AU - Harvey, P. AU - Gaunt, R. AU - Allgar, V. AU - Chipperfield, R. AU - Robinson, P. PY - 2010 DA - 2010// TI - Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets JO - Int J Clin Pract VL - 64 UR - https://doi.org/10.1111/j.1742-1241.2010.02429.x DO - 10.1111/j.1742-1241.2010.02429.x ID - McCormack2010 ER - TY - JOUR AU - Catapano, A. L. PY - 2009 DA - 2009// TI - Perspectives on low-density lipoprotein cholesterol goal achievement JO - Curr Med Res Opin VL - 25 UR - https://doi.org/10.1185/03007990802631438 DO - 10.1185/03007990802631438 ID - Catapano2009 ER - TY - JOUR AU - Genest, J. AU - McPherson, R. AU - Frohlich, J. AU - Anderson, T. AU - Campbell, N. AU - Carpentier, A. AU - Couture, P. AU - Dufour, R. AU - Fodor, G. AU - Francis, G. A. PY - 2009 DA - 2009// TI - 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations JO - Can J Cardiol VL - 25 UR - https://doi.org/10.1016/S0828-282X(09)70715-9 DO - 10.1016/S0828-282X(09)70715-9 ID - Genest2009 ER - TY - JOUR AU - Bays, H. E. AU - Neff, D. AU - Tomassini, J. E. AU - Tershakovec, A. M. PY - 2008 DA - 2008// TI - Ezetimibe: cholesterol lowering and beyond JO - Expert Rev Cardiovasc Ther VL - 6 UR - https://doi.org/10.1586/14779072.6.4.447 DO - 10.1586/14779072.6.4.447 ID - Bays2008 ER - TY - JOUR AU - Ballantyne, C. M. AU - Blazing, M. A. AU - King, T. R. AU - Brady, W. E. AU - Palmisano, J. PY - 2004 DA - 2004// TI - Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia JO - J Am Coll Cardiol VL - 43 UR - https://doi.org/10.1016/S0735-1097(04)92034-7 DO - 10.1016/S0735-1097(04)92034-7 ID - Ballantyne2004 ER - TY - JOUR AU - Farnier, M. AU - Averna, M. AU - Missault, L. AU - Vaverkova, H. AU - Viigimaa, M. AU - Massaad, R. AU - Vandormael, K. AU - Johnson-Levonas, A. O. AU - Brudi, P. PY - 2009 DA - 2009// TI - Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study JO - Int J Clin Pract VL - 63 UR - https://doi.org/10.1111/j.1742-1241.2009.02022.x DO - 10.1111/j.1742-1241.2009.02022.x ID - Farnier2009 ER - TY - JOUR AU - Van Himbergen, T. M. AU - Matthan, N. R. AU - Resteghini, N. A. AU - Otokozawa, S. AU - Ai, M. AU - Stein, E. A. AU - Jones, P. H. AU - Schaefer, E. J. PY - 2009 DA - 2009// TI - Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers JO - J Lipid Res VL - 50 UR - https://doi.org/10.1194/jlr.P800042-JLR200 DO - 10.1194/jlr.P800042-JLR200 ID - Van Himbergen2009 ER - TY - JOUR AU - Pisciotta, L. AU - Fasano, T. AU - Bellocchio, A. AU - Bocchi, L. AU - Sallo, R. AU - Fresa, R. AU - Colangeli, I. AU - Cantafora, A. AU - Calandra, S. AU - Bertolini, S. PY - 2007 DA - 2007// TI - Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients JO - Atherosclerosis VL - 194 UR - https://doi.org/10.1016/j.atherosclerosis.2006.10.036 DO - 10.1016/j.atherosclerosis.2006.10.036 ID - Pisciotta2007 ER - TY - JOUR AU - Alexander, K. P. AU - Blazing, M. A. AU - Rosenson, R. S. AU - Hazard, E. AU - Aronow, W. S. AU - Smith, S. C. AU - Ohman, E. M. PY - 2009 DA - 2009// TI - Management of hyperlipidemia in older adults JO - J Cardiovasc Pharmacol Ther VL - 14 UR - https://doi.org/10.1177/1074248408328927 DO - 10.1177/1074248408328927 ID - Alexander2009 ER - TY - JOUR AU - Davidson, M. PY - 2005 DA - 2005// TI - Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation JO - Prev Cardiol VL - 8 UR - https://doi.org/10.1111/j.0197-3118.2005.04078.x DO - 10.1111/j.0197-3118.2005.04078.x ID - Davidson2005 ER - TY - JOUR AU - Naessen, T. AU - Sjogren, U. AU - Bergquist, J. AU - Larsson, M. AU - Lind, L. AU - Kushnir, M. M. PY - 2010 DA - 2010// TI - Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women JO - J Clin Endocrinol Metab VL - 95 UR - https://doi.org/10.1210/jc.2009-1722 DO - 10.1210/jc.2009-1722 ID - Naessen2010 ER - TY - JOUR AU - Mangravite, L. M. AU - Medina, M. W. AU - Cui, J. AU - Pressman, S. AU - Smith, J. D. AU - Rieder, M. J. AU - Guo, X. AU - Nickerson, D. A. AU - Rotter, J. I. AU - Krauss, R. M. PY - 2010 DA - 2010// TI - Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin JO - Arterioscler Thromb Vasc Biol VL - 30 UR - https://doi.org/10.1161/ATVBAHA.110.203273 DO - 10.1161/ATVBAHA.110.203273 ID - Mangravite2010 ER - TY - JOUR AU - Conard, S. E. AU - Bays, H. E. AU - Leiter, L. A. AU - Bird, S. R. AU - Rubino, J. AU - Lowe, R. S. AU - Tomassini, J. E. AU - Tershakovec, A. M. PY - 2008 DA - 2008// TI - Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease JO - Am J Cardiol VL - 102 UR - https://doi.org/10.1016/j.amjcard.2008.09.075 DO - 10.1016/j.amjcard.2008.09.075 ID - Conard2008 ER - TY - JOUR AU - Leiter, L. A. AU - Bays, H. AU - Conard, S. AU - Bird, S. AU - Rubino, J. AU - Hanson, M. E. AU - Tomassini, J. E. AU - Tershakovec, A. M. PY - 2008 DA - 2008// TI - Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease JO - Am J Cardiol VL - 102 UR - https://doi.org/10.1016/j.amjcard.2008.09.076 DO - 10.1016/j.amjcard.2008.09.076 ID - Leiter2008 ER - TY - CHAP AU - Reckless, J. AU - Davies, G. AU - Tunceli, K. AU - Hu, X. H. AU - Brudi, P. PY - 2010 DA - 2010// TI - Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study BT - Value Health ID - Reckless2010 ER - TY - JOUR AU - Califf, R. M. AU - Lokhnygina, Y. AU - Cannon, C. P. AU - Stepanavage, M. E. AU - McCabe, C. H. AU - Musliner, T. A. AU - Pasternak, R. C. AU - Blazing, M. A. AU - Giugliano, R. P. AU - Harrington, R. A. PY - 2010 DA - 2010// TI - An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design JO - Am Heart J VL - 159 UR - https://doi.org/10.1016/j.ahj.2010.03.004 DO - 10.1016/j.ahj.2010.03.004 ID - Califf2010 ER -